In-depth guide

UPDATED FEB 2026

Hair Relaxer Lawsuit Black Women

Part of the Hair Relaxer Cancer investigation

The short answer

Hair relaxer lawsuits disproportionately affect Black women, who were the primary marketing target, comprise 60% of affected users, and face twice the uterine cancer mortality rate of white women. This is both a product liability and a racial justice case.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Why Black Women Are Disproportionately Affected

Black women are the primary consumers of chemical hair relaxers in the United States. Approximately 60% of participants who reported using straighteners in the NIH Sister Study were self-identified Black women. Black women use these products more frequently, begin use at younger ages (often in childhood), and consequently accumulate higher lifetime EDC exposure than any other demographic group.

The Marketing Machine

For decades, hair relaxer manufacturers aggressively marketed their products to Black women and girls through advertising in Black-owned media: Ebony, Jet, Essence, BET. Product names ("Dark & Lovely," "African Pride," "Just for Me") explicitly targeted Black consumers. Products were positioned as necessities for professional appearance — reinforcing discriminatory beauty standards that penalized natural Black hair.

Workplace Discrimination and Coercive Pressure

The CROWN Act movement exists because Black women faced documented employment and educational consequences for wearing natural hair. This discrimination created a coercive environment where chemical straightening felt mandatory for career advancement. The litigation argues that hair relaxer manufacturers profited from this systemic pressure while hiding the cancer risks of their products.

The Uterine Cancer Mortality Disparity

Black women die of uterine cancer at twice the rate of white women — one of the largest racial cancer mortality disparities documented in the United States. The hair relaxer litigation raises a pointed question: how much of this disparity was caused by an industry that marketed carcinogen-containing products specifically to Black women without disclosing the cancer risk?

Environmental Justice Framework

The Environmental Working Group found that personal care products marketed to Black women contain significantly higher concentrations of hazardous chemicals than mainstream products. The hair relaxer litigation is part of a broader environmental justice movement recognizing that communities of color bear disproportionate exposure to toxic chemicals — not by coincidence, but through corporate marketing decisions.

Research & evidence

Scientific Evidence

Hair Relaxer Use and Risk of Uterine Cancer in the Black Women's Health Study

Bertrand KA, Coogan PF, Palmer JR (2023). Environmental Research

View on PubMed

Use of Straighteners and Other Hair Products and Incident Uterine Cancer

Chang CJ, O'Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, White AJ (2022). Journal of the National Cancer Institute

View on PubMed

Use of Hair Products in Relation to Ovarian Cancer Risk

White AJ, Sandler DP, et al. (2021). Carcinogenesis

View on PubMed

FAQ

Frequently Asked Questions

36 QUESTIONS

Chemical hair relaxers contain endocrine-disrupting chemicals (EDCs) — phthalates, parabens, formaldehyde, BPA, and cyclosiloxanes — that mimic estrogen when absorbed through the scalp. Chronic estrogen overstimulation promotes abnormal growth in hormone-sensitive tissues. The NIH Sister Study found that frequent relaxer users face a 155% increased risk of uterine cancer and a 119% increased risk of ovarian cancer.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the Hair Relaxer Cancer Investigation